ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

CHU de Poitiers, Poitiers

CHA Bundang Medical Center, Seongnam-si

The Catholic University of Korea, St. Vincent's Hospital, Suwon

NEXT Virginia, Fairfax

Hospital Beata Maria Ana, Madrid

Clinica universitaria Navarra - Madrid, Madrid

START Madrid - Hospital Universitario Fundacion Jimenez Diaz, Madrid

BRCR Medical Center Inc., Plantation

Institut du Cancer de Montpellier - Val D'Aurelle, Montpellier

Washington University, St Louis

Institut de Cancérologie Strasbourg Europe, Strasbourg

Cliniques Universitaires Saint-Luc, Brussels

CHU de Liège, Liège

GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk

Institut de Cancérologie de l'Ouest, Saint-Herblain

Azienda Ospedaliero-Universitaria Renato Dulbecco, Catanzaro

Istituto Europeo di Oncologia, Milan

Fondazione IRCCS San Gerardo dei Tintori, Monza

Azienda Ospedaliero Universitaria Pisana, Pisa

Azienda USL IRCCS di Reggio Emilia, Reggio Emilia

Radboud UMC, Nijmegen

Seoul National University Hospital, Soeul

Hospital Universitari Dexeus - Grupo Quironsalud, Barcelona

Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON, Barcelona

Clinica univeritaria Navarra - Pamplonas, Pamplona

Fundacion Instituto Valenciano de Oncologia, Valencia

Fondazione Policlinico A. Gemelli IRCCS, Rome

Severance Hospital, Yonsei University Health System, Seoul

Asan Medical Center, Seoul

NEXT Oncology-Hospital Quironsalud Barcelona, Barcelona

START Barcelona_HM Nou Delfos, Barcelona